Pfizer says it has developed a new Covid-19 pill that reduces deaths and hospitalizations in high-risk patients by 89%

Pfizer says it has developed a new Covid-19 pill that reduces deaths and hospitalizations in high-risk patients by 89%

In Pfizer’s trial of 1,219 unvaccinated adults, five days of treatment with its drug dramatically reduced the rate of hospitalization when it was started within either three days or five days of symptom onset, the company said. The drug, #Paxlovid, binds to an enzyme called a protease to stop the virus from replicating itself. Some drugs for HIV work in a similar way.

https://www.bloomberg.com/news/articles/2021-11-05/pfizer-to-seek-u-s-nod-for-covid-pill-after-strong-results